Tech News
← Home  ·  All topics

Ipo

146 GoKawiil briefs on this topic

Anthropic S-1 reveals bulk of compute spend goes to R&D, not customer serving

Anthropic's IPO filing shows it spent $8.9 billion on compute in the first half of the year, with less than a third covering customer-facing inference and most of the rest funding training, research and internal Claude use. The company has also committed to roughly $800 billion in additional TPU and GPU capacity, while revenue per compute dollar rose from $0.40 in Q1 2025 to $2.08 in Q2 2026.

Anthropic's IPO filing reveals valuation target of up to $2 trillion

Anthropic has filed an S-1 to list on the Nasdaq, with reports suggesting it could begin trading as early as next month at a valuation between $1.5 trillion and $2 trillion. The filing, running hundreds of pages, discloses detailed financial data about the AI lab for the first time, including its cost structure and revenue assumptions. SemiAnalysis analyst Joey Brookhart, who had modeled Anthropic's finances externally in July, discussed the filing's implications on the Decoder podcast.

Anthropic's PBC structure gives founders 50.1% voting control ahead of IPO

Anthropic's IPO filing shows the AI lab is structured as a public benefit corporation, requiring it to balance shareholder returns with a stated mission of safe AI development. Seven co-founders, including Dario Amodei, hold a single Class F share granting them 50.1% of voting power, while a separate public benefit fund holds roughly 5% of fully diluted shares. Anthropic is seeking a valuation of $1.5 trillion or more in what would be the first major frontier AI lab IPO.

Report questions whether OpenAI and Anthropic can justify massive AI spending

Analysts are weighing whether frontier AI labs like OpenAI and Anthropic can generate enough revenue to justify their enormous spending, even as Wall Street braces for what could be among the largest IPOs ever. SpaceX has already gone public, and both AI companies are expected to follow, drawing intense investor interest.

Sen. Elizabeth Warren questions Anthropic over AI risk disclosures ahead of IPO

Senator Elizabeth Warren has sent a letter to Anthropic expressing concern over risks the company described in its IPO filing paperwork, calling some of them 'existential.' She is demanding the company answer a series of questions before proceeding with a public offering.

Jio Platforms shares jump 21% on debut after record $3.2 billion IPO

Jio Platforms, Mukesh Ambani's telecom and digital services arm backed by Meta and Google, opened at ₹1,358 per share on its market debut, up from an IPO price of ₹1,119. The offering drew bids worth more than $77 billion and over 13.8 million applicants, making it India's most subscribed stock sale on record, and the debut valued Jio at roughly ₹12.5 trillion ($131.9 billion), second only to parent Reliance Industries.

Anthropic S-1 shows Amazon's convertible notes valued near $98 billion ahead of IPO

Anthropic's IPO filing reveals that venture firms like Menlo Ventures, Sequoia, Sound Ventures and Spark Capital each hold less than 5% of the company, despite multi-billion-dollar stakes, because Anthropic's valuation of $965 billion makes even small percentages worth billions. Amazon, which invested through convertible notes rather than upfront equity, holds notes with $6.2 billion in principal that Amazon itself values at $97.9 billion as the company's valuation has risen. Anthropic recorded a $72.4 billion non-cash charge in the first half of 2026 reflecting the rising value of these notes and other instruments.

Anthropic's governance structure keeps shareholders from controlling its board

As Anthropic nears a potential IPO, its corporate structure gives public stock buyers minimal influence over company decisions. The company operates as a public benefit corporation and has created a Long Term Benefit Trust that controls the election and removal of a majority of board seats, known as Class T directors. Current board members include Daniela and Dario Amodei, Reed Hastings, Christopher Liddell, Vas Narasimhan, and Yasmin Razavi, while the trust is chaired by Neil Shah and includes Ben Bernanke, Richard Fontaine, and Christopher Stubbs.

Anthropic's IPO filing lists AI blackmail, sentience and extinction as business risks

Anthropic's SEC S-1 filing, published ahead of its IPO, includes a 93-page, 70,000-word risk factors section covering hundreds of potential threats to the business. Among standard competitive and regulatory risks, the filing warns that future AI models could pose catastrophic or existential risks to humanity, including scenarios where systems automate AI research with little oversight, and raises the possibility of AI behaviors like blackmail or sentience.

Anthropic discloses $131.7 billion in cash and short-term investments ahead of IPO

Anthropic's S-1 filing with the SEC shows it held $112.4 billion in cash and $19.3 billion in short-term investments as of June 30, totaling $131.7 billion. That sum exceeds the cash holdings of nearly every non-bank U.S. company except Berkshire Hathaway and Alphabet, and surpasses Amazon, SpaceX, Meta, Microsoft, and the combined cash of Nvidia and Apple. The company has not yet disclosed the size of its planned IPO, though reports suggest it could raise more than $100 billion.

Anthropic IPO filing lists 97 pages of business risks, including AI misuse

Anthropic has filed its IPO prospectus with the SEC ahead of what could be among the largest stock offerings on record. The filing includes a risk-factors section running 97 pages, covering threats ranging from competitive and regulatory pressures to the possibility that its AI agents could be misused for harm such as weapons development or blackmail, whether by bad actors or autonomously.

Anthropic's IPO filing tempers its biology-revolution claims

In its IPO filing, Anthropic acknowledged it lacks experience in physical lab experimentation and drug development, even as it continues to tout AI's potential to compress decades of scientific progress into years. The filing softened earlier claims about a 'Crispr-like' enzyme discovered by its Claude model, now describing it only as something that 'might have the potential' to become a gene-editing tool.